Pairing concentrated Lactobacillus salivarius with highly purified antioxidant enzymes, phospholipids, and essential metabolic intermediates.
Understanding strain persistence, bacteriocin biosynthesis, and thermodynamic stability protocols in multi-ton batch processing.
L. salivarius produces class II bacteriocins (Salivaricin B, A3, and CRL1328) with targeted activity against periodontal and gastrointestinal pathogens including Streptococcus mutans, Helicobacter pylori, and Salmonella enterica without disturbing commensal flora.
Bulk probiotic integrity relies on controlled lyophilization. Our facilities employ a triple-matrix cryoprotectant mixture (trehalose, sodium caseinate, and fructooligosaccharides) yielding ≥92% cell-wall membrane survival through post-freezing drying cycles.
Supplied in pharmaceutical-grade white to light cream powders with potency titers standardized from 100 Billion (1.0×10¹¹) CFU/g up to hyper-concentrated 500 Billion (5.0×10¹¹) CFU/g, verified via flow cytometry and classical serial dilution plate counts.
| Analytical Parameter | Reference Pharmacopeial Standard | Industrial Grade Titer | Pharma API Specification |
|---|---|---|---|
| Viable Cell Count (CFU/g) | ISO 19344 / IDF 232 (Flow Cytometry) | ≥ 1.0 × 10¹¹ CFU/g | ≥ 2.0 × 10¹¹ to 5.0 × 10¹¹ CFU/g |
| Moisture Content (LOD) | USP <731> Infrared Moisture Balance | ≤ 5.0% w/w | ≤ 3.0% w/w (Ultra-Dry) |
| Water Activity (aw) | Chilled Mirror Dewpoint Method | ≤ 0.15 aw | ≤ 0.10 aw (Capsule Integrity) |
| Heavy Metals (Pb, As, Cd, Hg) | USP <232> / <233> ICP-MS | < 5.0 ppm Total | < 1.0 ppm (Heavy Metals Compliant) |
| Non-Lactic Contaminants | GB 4789.35 / FDA BAM Ch. 18 | Absence / 25g | Zero Detection (Total Negative Screen) |
Overcoming microbiological variability with automated SCADA systems, in-line cell harvesting, and dedicated GMP cleanrooms.
Continuous closed-loop dissolved oxygen (DO) monitoring and automated carbon/nitrogen balance feeds mitigate osmotic shock and maximize log-phase viability during biomass production.
Continuous-flow cold disk-stack centrifuges concentrate bacterial pastes at <4°C, preserving structural integrity before entering cryogenic blast freezers at -45°C.
Lyophilized cake pulverization and nitrogen-flushed blending take place in ISO Class 7/8 controlled atmospheres with constant relative humidity controlled below 25%.
Temperature-logged dry ice and eutectic phase-change gel packaging guarantee thermal continuity from the Xi'an facility through international sea/air freight terminals.
From oral cavity microecology to dermatological postbiotics and veterinary therapeutics.
Unlike acid-tolerant gut species that can erode enamel, select L. salivarius strains metabolize carbohydrates without causing dental demineralization, displacing pathogens like Porphyromonas gingivalis in chewables, lozenges, and oral rinses.
Heat-inactivated Lactobacillus salivarius ferments and lysate fractions reduce cutibacterium acnes colonization while regulating human beta-defensin-2 expressions in functional cosmetics, creams, and skin barrier rebalancing serums.
Micro-encapsulated feed-grade Lactobacillus salivarius replaces prophylactic sub-therapeutic antibiotics in swine and poultry broilers, directly improving intestinal villi height-to-crypt depth ratios and survivability against avian pathogenic E. coli.
Streamlining the friction of international customs, GRAS validations, EFSA QPS dossiers, and pharmaceutical audits.
Whole-genome sequencing (WGS) proves absence of transferable antimicrobial resistance genes (tetracycline, vancomycin, ampicillin) per EFSA guidelines, guaranteeing safety in food, diet, and therapeutic formulations.
Batch-specific release includes Certificate of Analysis (COA), safety data sheets (MSDS/SDS), Non-GMO statements, BSE/TSE-free attestations, allergen disclosures, and Kosher/Halal certification documents.
Customs-ready paperwork customized for FDA Dietary Supplement Health and Education Act (DSHEA) notification in the USA, EU Novel Food classification, and ASEAN traditional medicine/supplement guidelines.
What contract manufacturers, pharma groups, and multinational brand buyers evaluate when selecting bulk probiotic partners.
Brand formulators rarely pack pure probiotics. When combining L. salivarius with botanical polyphenol extracts (e.g., green tea or quercetin) or hygroscopic minerals (e.g., magnesium malate), enterprise buyers demand micro-lipid encapsulation to prevent premature active oxidation and loss of live counts during blending and 24-month shelf life storage.
Strategic purchasing managers evaluate price per active billion CFU at time of product expiration rather than merely at time of blending. High thermal-stability bulk batches reduce the required manufacturing overages (often saving 15% to 30% in raw input costs per finished container), drastically optimizing product profitability.
Pioneering synthetic biology insights, anaerobic consortia formulations, and room-temperature stable delivery formats.
Deploying directional evolution to cultivate Lactobacillus salivarius substrains with heat-shock protein expression upregulation, enabling 24-month room temperature ambient stability in tropical climates (Zone IVb stability testing).
Mapping high-molecular-weight EPS structures produced by specific Lactobacillus salivarius strains to modulate mucosal immune signaling, cytokine release (IL-10/TNF-α balancing), and intestinal junction barrier tight binding.
Synergistic co-cultivation platforms combining Lactobacillus salivarius with Bifidobacterium species and postbiotic substrates, pre-stabilized inside uniform granules designed for direct powder stick-packs and effervescent delivery systems.
Critical operational, testing, and handling clarifications for seamless bulk probiotic procurement.
Consolidating your supply chain with certified cosmeceuticals, liposomal formulations, and botanical extracts.